PMC:7558333 / 0-662 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":651,"end":656},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma9670"}],"text":"Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience\n\nAbstract\n(1) Background: The diagnosis of invasive aspergillosis (IA) in an intensive care unit (ICU) remains a challenge and the COVID-19 epidemic makes it even harder. Here, we evaluated Aspergillus PCR input to help classifying IA in SARS-CoV-2-infected patients. (2) Methods: 45 COVID-19 patients were prospectively monitored twice weekly for Aspergillus markers and anti-Aspergillus serology. We evaluated the concordance between (I) Aspergillus PCR and culture in respiratory samples, and (II) blood PCR a"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":651,"end":656},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience\n\nAbstract\n(1) Background: The diagnosis of invasive aspergillosis (IA) in an intensive care unit (ICU) remains a challenge and the COVID-19 epidemic makes it even harder. Here, we evaluated Aspergillus PCR input to help classifying IA in SARS-CoV-2-infected patients. (2) Methods: 45 COVID-19 patients were prospectively monitored twice weekly for Aspergillus markers and anti-Aspergillus serology. We evaluated the concordance between (I) Aspergillus PCR and culture in respiratory samples, and (II) blood PCR a"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":7,"end":15},"obj":"Disease"},{"id":"T2","span":{"begin":94,"end":107},"obj":"Disease"},{"id":"T3","span":{"begin":193,"end":215},"obj":"Disease"},{"id":"T4","span":{"begin":202,"end":215},"obj":"Disease"},{"id":"T5","span":{"begin":217,"end":219},"obj":"Disease"},{"id":"T6","span":{"begin":281,"end":289},"obj":"Disease"},{"id":"T7","span":{"begin":382,"end":384},"obj":"Disease"},{"id":"T8","span":{"begin":388,"end":396},"obj":"Disease"},{"id":"T9","span":{"begin":434,"end":442},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience\n\nAbstract\n(1) Background: The diagnosis of invasive aspergillosis (IA) in an intensive care unit (ICU) remains a challenge and the COVID-19 epidemic makes it even harder. Here, we evaluated Aspergillus PCR input to help classifying IA in SARS-CoV-2-infected patients. (2) Methods: 45 COVID-19 patients were prospectively monitored twice weekly for Aspergillus markers and anti-Aspergillus serology. We evaluated the concordance between (I) Aspergillus PCR and culture in respiratory samples, and (II) blood PCR a"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":25,"end":26},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":125,"end":126},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T3","span":{"begin":261,"end":262},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T4","span":{"begin":431,"end":433},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"},{"id":"T5","span":{"begin":651,"end":656},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T6","span":{"begin":651,"end":656},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"}],"text":"Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience\n\nAbstract\n(1) Background: The diagnosis of invasive aspergillosis (IA) in an intensive care unit (ICU) remains a challenge and the COVID-19 epidemic makes it even harder. Here, we evaluated Aspergillus PCR input to help classifying IA in SARS-CoV-2-infected patients. (2) Methods: 45 COVID-19 patients were prospectively monitored twice weekly for Aspergillus markers and anti-Aspergillus serology. We evaluated the concordance between (I) Aspergillus PCR and culture in respiratory samples, and (II) blood PCR a"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":124},"obj":"Sentence"},{"id":"T2","span":{"begin":125,"end":149},"obj":"Sentence"},{"id":"T3","span":{"begin":151,"end":159},"obj":"Sentence"},{"id":"T4","span":{"begin":160,"end":175},"obj":"Sentence"},{"id":"T5","span":{"begin":176,"end":320},"obj":"Sentence"},{"id":"T6","span":{"begin":321,"end":430},"obj":"Sentence"},{"id":"T7","span":{"begin":431,"end":548},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience\n\nAbstract\n(1) Background: The diagnosis of invasive aspergillosis (IA) in an intensive care unit (ICU) remains a challenge and the COVID-19 epidemic makes it even harder. Here, we evaluated Aspergillus PCR input to help classifying IA in SARS-CoV-2-infected patients. (2) Methods: 45 COVID-19 patients were prospectively monitored twice weekly for Aspergillus markers and anti-Aspergillus serology. We evaluated the concordance between (I) Aspergillus PCR and culture in respiratory samples, and (II) blood PCR a"}

{"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":115,"end":123},"obj":"Species"},{"id":"4","span":{"begin":48,"end":59},"obj":"Species"},{"id":"5","span":{"begin":7,"end":15},"obj":"Disease"},{"id":"23","span":{"begin":408,"end":416},"obj":"Species"},{"id":"24","span":{"begin":443,"end":451},"obj":"Species"},{"id":"29","span":{"begin":340,"end":351},"obj":"Species"},{"id":"30","span":{"begin":498,"end":509},"obj":"Species"},{"id":"31","span":{"begin":527,"end":538},"obj":"Species"},{"id":"32","span":{"begin":590,"end":601},"obj":"Species"},{"id":"35","span":{"begin":193,"end":215},"obj":"Disease"},{"id":"36","span":{"begin":281,"end":289},"obj":"Disease"},{"id":"37","span":{"begin":388,"end":407},"obj":"Disease"},{"id":"38","span":{"begin":434,"end":442},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"Tax:9606"},{"id":"A4","pred":"tao:has_database_id","subj":"4","obj":"Tax:746128"},{"id":"A5","pred":"tao:has_database_id","subj":"5","obj":"MESH:C000657245"},{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"Tax:9606"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"Tax:9606"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"Tax:746128"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"Tax:746128"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"Tax:746128"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"Tax:746128"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"MESH:D055744"},{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"MESH:C000657245"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"MESH:C000657245"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience\n\nAbstract\n(1) Background: The diagnosis of invasive aspergillosis (IA) in an intensive care unit (ICU) remains a challenge and the COVID-19 epidemic makes it even harder. Here, we evaluated Aspergillus PCR input to help classifying IA in SARS-CoV-2-infected patients. (2) Methods: 45 COVID-19 patients were prospectively monitored twice weekly for Aspergillus markers and anti-Aspergillus serology. We evaluated the concordance between (I) Aspergillus PCR and culture in respiratory samples, and (II) blood PCR a"}